Directly Observed Therapy in HIV Infected Adolescent Focus Groups

Completed

Conditions studied: HIV Infections

In brief

The purpose of this study is to help researchers use information from HIV infected adolescents to design a directly observed therapy (DOT) program that will help adolescents take their anti-HIV medications correctly.

Key facts

Study ID

NCT00079729

Run by

National Institute of Allergy and Infectious Diseases (NIAID)

People needed

30

Starts

2004-04-01

Expected to finish

2004-07-01

Last updated by the study team

2012-10-29

Who can join

Age: 16 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV infected due to high-risk behavior
• Regular attendee of local adolescent HIV support group
• Current use of antiretrovirals or history of antiretroviral therapy
• Permission of parent or legal guardian if participant is less than the legal age of consent. Assent of the minor participant should be obtained where required.

You may not qualify if…

• Perinatal HIV infection
• Visibly distraught or emotionally unstable
• Pregnancy or breast-feeding

Where it is running

• Los Angeles County Medical Center/USC — Los Angeles, California, United States
• University of Miami (Pediatric) — Miami, Florida, United States
• St. Jude Childrens Research Hospital, Memphis — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.